Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Rigel Pharmaceuticals Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- +4 vs. Q2 2024
- Shares held
- 11.9M
- +3.03M (+34.1%) vs. Q2 2024
- Total value
- $192.6M
- +$119.6M (+164.0%) vs. Q2 2024
- New holders
- 22
- 30 more added
- Sold out
- 18
- 24 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 155 | $640.4M |
| Q1 2026 | 159 | $432.8M |
| Q4 2025 | 194 | $690.5M |
| Q3 2025 | 169 | $425.6M |
| Q2 2025 | 126 | $260.2M |
| Q1 2025 | 123 | $250.2M |
| Q4 2024 | 122 | $203.0M |
| Q3 2024 | 93 | $192.6M |
| Q2 2024 | 91 | $85.4M |
| Q1 2024 | 117 | $164.3M |
| Q4 2023 | 113 | $154.5M |
| Q3 2023 | 106 | $114.8M |
| Q2 2023 | 118 | $142.7M |
| Q1 2023 | 125 | $148.6M |
| Q4 2022 | 118 | $163.1M |
| Q3 2022 | 138 | $150.3M |
| Q2 2022 | 135 | $157.2M |
| Q1 2022 | 163 | $405.7M |
| Q4 2021 | 162 | $365.9M |
| Q3 2021 | 163 | $499.6M |
| Q2 2021 | 160 | $614.5M |
| Q1 2021 | 152 | $493.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Rigel Pharmaceuticals Inc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −17,667−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −17,094−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −16,208−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −11,029−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −1,034−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −211−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −136−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −450−100.0% | Sold out |
| Abich Financial Wealth Management LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Institutional & Family Asset Management, LLC | – | – | – | – | Not filed |